Phil Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 98
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $25M
Latest Deal Amount
  • Investors
  • 15

Phil General Information

Description

Operator of an end-to-end healthcare platform created to make specialty drugs more available and affordable to consumers. The company's platform connects patients, prescribers, pharmacies and manufacturers and provides an end-to-end prescription management service as a convenient alternative to traditional pharmaceutical management, thus enabling patients to get access to low-cost medicines and better outcomes to rare diseases.

Contact Information

Website
Formerly Known As
REX Technology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Information Services (B2C)
Media and Information Services (B2B)
Other Healthcare Technology Systems
Primary Office
  • 234 Front Street
  • 4th Floor
  • San Francisco, CA 94111
  • United States
+1 (855) 000-0000

Phil Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Phil Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 15-May-2019 $25M 000.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 16-Aug-2017 0000 000.00 Completed Generating Revenue
2. Early Stage VC 29-Nov-2016 $7.5M $9.6M 000.00 Completed Generating Revenue
1. Seed Round 01-Aug-2015 $2.11M $2.11M Completed Startup
To view Phil’s complete valuation and funding history, request access »

Phil Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 4,125,112 $0.000010 8% $0.51 $0.51 1x $0.51 8.59%
To view Phil’s complete cap table history, request access »

Phil Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of an end-to-end healthcare platform created to make specialty drugs more available and affordable to consumers
Other Healthcare Services
San Francisco, CA
98 As of 2020
000.00
00.00 0000-00-00
00000000000 000.00

00000000

em ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
00000 0000000000 00000000
San Diego, CA
0000 As of 0000
00000
0000 00000

000000

a. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
0000000000 0000000 (0000000000)
Boston, MA
00 As of 0000
000.00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phil Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MedImpact HealthCare Systems Formerly PE-Backed San Diego, CA 0000 00000 0000 00000
000000 Formerly VC-backed Boston, MA 00 000.00 000000&0 000.00
000000000 Corporation Mission, KS
000000 000000 Formerly VC-backed Plano, TX 00 000.00 000000&0 000.00
0000000 Formerly VC-backed Jersey City, NJ 00 000.00 000000&0 000.00
You’re viewing 5 of 13 competitors. Get the full list »

Phil Executive Team (4)

Name Title Board Seat Contact Info
Deepak Thomas Founder, Chief Executive Officer & Board Member
Will Goldfarb JD Head, Business Operations
Fang-Yu Lin Head of Products & Design
To view Phil’s complete executive team members history, request access »

Phil Board Members (2)

Name Representing Role Since
Deepak Thomas Phil Founder, Chief Executive Officer & Board Member 000 0000
Omar El-Ayat Crosslink Capital Board Member 000 0000
To view Phil’s complete board members history, request access »

Phil Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phil Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Avtar Investments Family Office Minority 000 0000 000000 0
GreatPoint Ventures Venture Capital Minority 000 0000 000000 0
Proton Enterprises Venture Capital Minority 000 0000 000000 0
Tarsadia Investments Family Office Minority 000 0000 000000 0
Hedgewood Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »